Davis SR - Search Results

1

Global Consensus Position Statement on the Use of Testosterone Therapy for Women.

Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton J, Rymer J, Simon JA, Vignozzi L, Wierman ME. Davis SR, et al. J Clin Endocrinol Metab. 2019 Oct 1;104(10):4660-4666. doi: 10.1210/jc.2019-01603. J Clin Endocrinol Metab. 2019. PMID: 31498871 Free PMC article.

2

Should women be treated with testosterone?

Burger H, Davis S. Burger H, et al. Clin Endocrinol (Oxf). 1998 Aug;49(2):159-60. doi: 10.1046/j.1365-2265.1998.00524.x. Clin Endocrinol (Oxf). 1998. PMID: 9828899 No abstract available.

3

Androgen replacement in women: a commentary.

Davis S. Davis S. J Clin Endocrinol Metab. 1999 Jun;84(6):1886-91. doi: 10.1210/jcem.84.6.5802. J Clin Endocrinol Metab. 1999. PMID: 10372681 Review.

4

Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment.

Bachmann G, Bancroft J, Braunstein G, Burger H, Davis S, Dennerstein L, Goldstein I, Guay A, Leiblum S, Lobo R, Notelovitz M, Rosen R, Sarrel P, Sherwin B, Simon J, Simpson E, Shifren J, Spark R, Traish A; Princeton. Bachmann G, et al. Fertil Steril. 2002 Apr;77(4):660-5. doi: 10.1016/s0015-0282(02)02969-2. Fertil Steril. 2002. PMID: 11937111 Free article. Review.

5

Transition from estrogen therapy to raloxifene in postmenopausal women: effects on treatment satisfaction and the endometrium-a pilot study.

Davis SR, O'Neill SM, Eden J, Baber R, Ekangaki A, Stocks JM, Thiebaud D. Davis SR, et al. Menopause. 2004 Mar-Apr;11(2):167-75. doi: 10.1097/01.gme.0000087981.28957.cf. Menopause. 2004. PMID: 15021446 Clinical Trial.

6

Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.

Simon J, Braunstein G, Nachtigall L, Utian W, Katz M, Miller S, Waldbaum A, Bouchard C, Derzko C, Buch A, Rodenberg C, Lucas J, Davis S. Simon J, et al. J Clin Endocrinol Metab. 2005 Sep;90(9):5226-33. doi: 10.1210/jc.2004-1747. Epub 2005 Jul 12. J Clin Endocrinol Metab. 2005. PMID: 16014407 Clinical Trial.

7

Androgen therapy in women: an Endocrine Society Clinical Practice guideline.

Wierman ME, Basson R, Davis SR, Khosla S, Miller KK, Rosner W, Santoro N. Wierman ME, et al. Among authors: davis sr. J Clin Endocrinol Metab. 2006 Oct;91(10):3697-710. doi: 10.1210/jc.2006-1121. Epub 2006 Oct 3. J Clin Endocrinol Metab. 2006. PMID: 17018650

8

Are the endocrine society's clinical practice guidelines on androgen therapy in women misguided? A commentary-response.

Wierman M, Basson R, Davis S, Khosla S, Miller K, Rosner W, Santoro N. Wierman M, et al. J Sex Med. 2007 Nov;4(6):1782-3; author reply 1784-5. doi: 10.1111/j.1743-6109.2007.00623.x. J Sex Med. 2007. PMID: 17970980 No abstract available.

9

The incidence of invasive breast cancer among women prescribed testosterone for low libido.

Davis SR, Wolfe R, Farrugia H, Ferdinand A, Bell RJ. Davis SR, et al. J Sex Med. 2009 Jul;6(7):1850-6. doi: 10.1111/j.1743-6109.2009.01289.x. Epub 2009 Apr 24. J Sex Med. 2009. PMID: 19453875

10

Should women receive androgen replacement therapy, and if so, how?

Davis SR. Davis SR. Clin Endocrinol (Oxf). 2010 Feb;72(2):149-54. doi: 10.1111/j.1365-2265.2009.03670.x. Epub 2009 Jul 24. Clin Endocrinol (Oxf). 2010. PMID: 19650781

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

608 results

Search Page